Fig. 5From: Cost-effectiveness analysis of atezolizumab in advanced triple-negative breast cancerCost-effectiveness acceptability curves showing the probability of each intervention being cost-effective over a range of cost-effectiveness thresholds. Separate curves were presented for different cost scenariosBack to article page